Basel, 05 November 2019
Reminder: Invitation to Roche's live audio webcast on Gazyva in lupus nephritis presented at ASN / ACR 2019
We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Tuesday, 12 November 2019, highlighting Roche data in lupus nephritis presented at the American Society of Nephrology (7 - 10 Nov) as well as the American College of Rheumatology Annual Meetings (8 - 13 Nov) in Washington, DC and Atlanta, United States, respectively.
Please dial in as outlined below:
16:30 - 17:30 CET / 15:30 - 16:30 GMT
10:30 - 11:30 am EST / 07:30 - 8:30 am PST
Audio webcast and conference call will start with presentations followed by a Q&A session (live access to the speakers).
Agenda
-
Welcome
Karl Mahler, Head of Investor Relations -
Roche in immunology
Mark Eisner, Global Head of Product Development - Immunology, Infectious Disease & Ophthalmology -
Phase II Nobility data - efficacy and safety of obinutuzumab or placebo in combination with mycophenolate mofetil in patients with Lupus Nephritis
Larry Tsai, Global Head of Rheumatology & Respiratory Development - Q&A
Access to Audio webcast
Please access by clicking on ir.roche.com.
Access to Conference Call (pre-registration required)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.
Should you have any issues with the registration, please dial the following numbers on the day of the conference call 10-15 minutes prior to conference start:
+41 (0) 58 310 5000 (Europe & RoW)
+44 (0) 207 107 0613 (UK)
+1 631 570 5613 (USA)
A replay of the webcast will be available via ir.roche.com.
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 05 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 November 2019 09:14:15 UTC